Moreover, several reports have documented that caveolin-1 expression is altered in various cancers, such as bladder, ovarian, thyroid follicular, breast, esophageal, lung, colon, cervical, and renal cancer; T cell leukemia; and HCC [25, 27–31]. This evidence concerns the gene CAV1 and hepatocellular carcinoma.